FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Remus Pharmaceuticals IPO.
April 24, 2024 10:40:10 AM
SME listed stocks are seen outperforming the key benchmark indices in CY24 even after SEBI cautioned about possibilities of some froth in small caps and SME market segment.
Published by : moneycontrol.com on MSNApril 26, 2024 2:30:00 PM
Shares of cybersecurity startup Rubrik rose on their first day of trading, reflecting how the IPO market for enterprise software startups has started to come back to life, but only for a limited group ...
Published by : Wall Street Journal on MSNApril 19, 2024 3:30:00 AM
Remus Pharmaceuticals Ltd share price was up by 1.36% from the previous closing price of ?6,101.00. Who are peers of Remus Pharmaceuticals Ltd? The peers of Remus Pharmaceuticals Ltd are Sun ...
Published by : Business TodayApril 25, 2024 9:00:00 PM
A trio of IPOs are a rare bright spot in Thursday�s market. Major U.S. stock indexes are in the red today, but Rubrik, Loar Holdings and Marex Group are all trading higher in their stock-market debuts ...
Published by : Wall Street JournalApril 1, 2024 7:50:00 AM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Published by : InvestingMay 31, 2023 7:42:00 PM
60 Degrees Pharmaceuticals, Inc (NASDAQ:SXTP) IPO will take place June, 01 on the NASDAQ exchange under the ticker SXTP. The company is offering shares at an expected price between $4.30 and $6.30 ...
Published by : MSNMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechOctober 9, 2020 3:30:00 AM
InMed Pharmaceuticals (INM) has filed to raise $10 million from the sale of common stock and warrants in an uplisting / Nasdaq IPO, according to an amended registration statement. Vancouver ...
Published by : TheStreet.comApril 19, 2024 3:30:00 AM
Questcor Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders.
Published by : ForbesSeptember 5, 2012 7:34:00 PM
Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the development and commercialization of life ...
Published by : ForbesApril 22, 2024 7:29:00 PM
Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology products, anti-infectives ...
Published by : Seeking AlphaThe IPO Shares of Remus Pharmaceuticals Limited IPO are proposed to list on Monday, May 29, 2023 at NSE SME. The public issue of Remus Pharmaceuticals IPO was opened on May 17, 2023 and closed for subscription on May 19, 2023. Remus Pharmaceuticals IPO Listing Date and Information:
Listing Date | Monday, May 29, 2023 |
BSE Script Code | |
NSE Symbol | REMUS |
Listing In | |
ISIN | INE0O5T01011 |
Issue Price | ₹1229 Per Equity Share |
Face Value | ₹10 Per Equity Share |
The allotment status of Remus Pharmaceuticals Limited IPO is now available online. The public issue of Remus Pharmaceuticals IPO was open on May 17, 2023 and closed for subscription on May 19, 2023. The equity shares of the company to be list at NSE SME
.
Remus Pharmaceuticals Limited is entering in the capital market with an IPO of 388,000 Equity Shares of Rs 10 aggregating up to Rs 47.69 Crore. The price for the issue has been set at Rs 1150 - Rs 1229 Per Equity Share.
Incorporated in 2015, Remus Pharmaceuticals Limited is engaged in the marketing and distributing of finished formulations of pharmaceutical drugs.
The issue opens on May 17, 2023 and closes for subscription on May 19, 2023. The equity shares of the company to be list at NSE SME.
The issue of Remus Pharmaceuticals Limited opens on May 17, 2023 and closes for subscription on May 19, 2023. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 1150 - Rs 1229 Per Equity Share.
The Remus Pharmaceuticals IPO is proposed to open on May 17, 2023. The IPO application ends on May 19, 2023.
Retail investors can apply in the retail or non-institutional investor category from May 17, 2023 to May 19, 2023. The Remus Pharmaceuticals IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Remus Pharmaceuticals IPO will open for subscription on May 17, 2023. The public issue will close on May 19, 2023.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|